Abstract
It is widely held among the general population and even among health professionals
that moderate exercise is a healthy practice but long term high intensity exercise
is not. The specific amount of physical activity necessary for good health remains
unclear. To date, longevity studies of elite athletes have been relatively sparse
and the results are somewhat conflicting. The Tour de France is among the most gruelling
sport events in the world, during which highly trained professional cyclists undertake
high intensity exercise for a full 3 weeks. Consequently we set out to determine the
longevity of the participants in the Tour de France, compared with that of the general
population. We studied the longevity of 834 cyclists from France (n=465), Italy (n=196)
and Belgium (n=173) who rode the Tour de France between the years 1930 and 1964. Dates
of birth and death of the cyclists were obtained on December 31st 2007. We calculated the percentage of survivors for each age and compared them with
the values for the pooled general population of France, Italy and Belgium for the
appropriate age cohorts. We found a very significant increase in average longevity
(17%) of the cyclists when compared with the general population. The age at which
50% of the general population died was 73.5 vs. 81.5 years in Tour de France participants.
Our major finding is that repeated very intense exercise prolongs life span in well
trained practitioners. Our findings underpin the importance of exercising without
the fear that becoming exhausted might be bad for one's health.
Key words
life expectancy - mortality - physical activity - endurance - lifestyle
References
1
Blair SN, LaMonte MJ, Nichaman MZ.
The evolution of physical activity recommendations: how much is enough?.
Am J Clin Nutr.
2004;
79
913S-920S
2
Chakravarty EF, Hubert HB, Lingala VB, Fries JF.
Reduced disability and mortality among aging runners: a 21-year longitudinal study.
Arch Intern Med.
2008;
168
1638-1646
3
Church TS, Earnest CP, Skinner JS, Blair SN.
Effects of different doses of physical activity on cardiorespiratory fitness among
sedentary, overweight or obese postmenopausal women with elevated blood pressure:
a randomized controlled trial.
JAMA.
2007;
297
2081-2091
4
Fogelholm M, Kaprio J, Sarna S.
Healthy lifestyles of former Finnish world class athletes.
Med Sci Sports Exerc.
1994;
26
224-229
5
Gomez-Cabrera MC, Pallardo FV, Sastre J, Vina J, Garcia-del-Moral L.
Allopurinol and markers of muscle damage among participants in the Tour de France.
JAMA.
2003;
289
2503-2504
6
Harris KM, Henry JT, Rohman E, Haas TS, Maron BJ.
Sudden death during the triathlon.
JAMA.
2010;
303
1255-1257
7
Harriss DJ, Atkinson G.
International Journal of Sports Medicine – Ethical Standards in Sport and Exercise
Science Research.
Int J Sports Med.
2009;
30
701-702
8
Kesaniemi YK, Danforth Jr E, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA.
Dose-response issues concerning physical activity and health: an evidence-based symposium.
Med Sci Sports Exerc.
2001;
33
S351-S358
9
Knez WL, Coombes JS, Jenkins DG.
Ultra-endurance exercise and oxidative damage: implications for cardiovascular health.
Sports Med.
2006;
36
429-441
10
Kujala UM.
Essay: Does training adversely affect long-term health?.
Lancet.
2005;
366
(S 01)
S55-S56
11
Kujala UM, Tikkanen HO, Sarna S, Pukkala E, Kaprio J, Koskenvuo M.
Disease-specific mortality among elite athletes.
JAMA.
2001;
285
44-45
12
Lee DC, Artero EG, Sui X, Blair SN.
Mortality trends in the general population: the importance of cardiorespiratory fitness.
J Psychopharmacol.
2010;
24
27-35
13
Lee IM.
Dose-response relation between physical activity and fitness: even a little is good;
more is better.
JAMA.
2007;
297
2137-2139
14
Lucia A, Hoyos J, Chicharro JL.
Physiology of professional road cycling.
Sports Med.
2001;
31
325-337
15
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE.
Exercise capacity and mortality among men referred for exercise testing.
N Engl J Med.
2002;
346
793-801
16
Paffenbarger Jr RS, Hyde RT, Wing AL, Hsieh CC.
Physical activity, all-cause mortality, and longevity of college alumni.
N Engl J Med.
1986;
314
605-613
17
Ruiz JR, Moran M, Arenas J, Lucia A.
Strenuous endurance exercise improves life expectancy: itâs in our genes.
Br J Sports Med.
2010;
DOI: doi:10.1136/bjsm.2010.075085
18
Sarna S, Sahi T, Koskenvuo M, Kaprio J.
Increased life expectancy of world class male athletes.
Med Sci Sports Exerc.
1993;
25
237-244
19
Schnohr P.
Athletic activity and longevity.
Lancet.
1972;
2
605
20
Schnohr P.
Longevity and causes of death in male athletic champions.
Lancet.
1971;
2
1364-1366
21
Sun Q, Townsend MK, Okereke OI, Franco OH, Hu FB, Grodstein F.
Physical activity at midlife in relation to successful survival in women at age 70
years or older.
Arch Intern Med.
2010;
170
194-201
22
Teramoto M, Bungum TJ.
Mortality and longevity of elite athletes.
J Sci Med Sport.
2010;
13
410-416
23
Woodcock J, Franco OH, Orsini N, Roberts I.
Non-vigorous physical activity and all-cause mortality: systematic review and meta-analysis
of cohort studies.
Int J Epidemiol.
2010;
DOI: doi: 10.1093/ije/dyq104
Correspondence
Dr. Mari Carmen Gomez-CabreraPhD
Department of Physiology
Faculty of Medicine
University of Valencia
Avda. Blasco Ibañez 15
46013 Valencia
Spain
Phone: + 34/963/864 646
Fax: + 34/963/864 642
Email: carmen.gomez@uv.es